151 related articles for article (PubMed ID: 6553515)
21. Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha.
Papanastasiou M; Baxevanis CN; Papamichail M
Cancer Immunol Immunother; 1992; 35(2):145-50. PubMed ID: 1596938
[TBL] [Abstract][Full Text] [Related]
22. Combined effect of fluconazole and thymosin alpha 1 on systemic candidiasis in mice immunosuppressed by morphine treatments.
di Francesco P; Gaziano R; Casalinuovo IA; Belogi L; Palamara AT; Favalli C; Garaci E
Clin Exp Immunol; 1994 Sep; 97(3):347-52. PubMed ID: 8082290
[TBL] [Abstract][Full Text] [Related]
23. Potentiatied antitumor effectiveness of combined chemo-immunotherapy with interleukin-12 and 5-fluorouracil of L1210 leukemia in vivo.
Goł b J; Zagozdzon R; Kamiński R; Kozar K; Gryska K; Izycki D; Mackiewicz A; Stokłosa T; Giermasz A; Lasek W; Jakóbisiak M
Leukemia; 2001 Apr; 15(4):613-20. PubMed ID: 11368364
[TBL] [Abstract][Full Text] [Related]
24. Recovery of T-cell functions in aged mice injected with synthetic thymosin-alpha 1.
Frasca D; Garavini M; Doria G
Cell Immunol; 1982 Sep; 72(2):384-91. PubMed ID: 6758954
[No Abstract] [Full Text] [Related]
25. Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.
Pica F; Mastino A; Grelli S; Jezzi T; Favalli C
J Chemother; 1989 Jul; 1(4 Suppl):1167-9. PubMed ID: 16312818
[No Abstract] [Full Text] [Related]
26. Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment.
Wampler GL; Carter WH; Campbell ED
Cancer Invest; 1987; 5(6):523-33. PubMed ID: 3442730
[TBL] [Abstract][Full Text] [Related]
27. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
28. The effect of thymosin on glucocorticoid receptors in lymphoid cells.
Osheroff PL
Cell Immunol; 1981 May; 60(2):376-85. PubMed ID: 6972268
[No Abstract] [Full Text] [Related]
29. Protective activity of thymosin against opportunistic infections in animal models.
Ishitsuka H; Umeda Y; Nakamura J; Yagi Y
Cancer Immunol Immunother; 1983; 14(3):145-50. PubMed ID: 6404549
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.
Mastino A; Favalli C; Grelli S; Rasi G; Pica F; Goldstein AL; Garaci E
Int J Cancer; 1992 Feb; 50(3):493-9. PubMed ID: 1735618
[TBL] [Abstract][Full Text] [Related]
31. The mechanism of augmentation of natural killer cell activity by syngeneic tumor cells: role of macrophage-derived factor in NK boosting.
Kawase I; Urdal DL; Newman W; Henney CS
Int J Cancer; 1983 Mar; 31(3):365-72. PubMed ID: 6402456
[TBL] [Abstract][Full Text] [Related]
32. [Effect of thymosin alpha 1 on cellular immune function in elderly patients with malignant tumor].
Yang YM; Lu XY; Huang WD; Shen MY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):339-41. PubMed ID: 12970939
[TBL] [Abstract][Full Text] [Related]
33. Induction of immune resistance against L1210 lymphatic leukemia in mice after lethal irradiation and reconstruction with fetal liver cells.
Skórski T; Ratajczak MZ; Kawalec M; Kawiak J
Folia Histochem Cytobiol; 1991; 29(3):121-4. PubMed ID: 1794437
[TBL] [Abstract][Full Text] [Related]
34. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
Góra-Tybor J; Robak T
Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
[TBL] [Abstract][Full Text] [Related]
35. [Thymosin activation of T-killer precursors for hematopoietic stem cells].
Chermeneva LM; Arion VIa; Gladysheva TV; Petrov RV; Khaitov RM
Biull Eksp Biol Med; 1978 May; 85(5):602-5. PubMed ID: 306843
[TBL] [Abstract][Full Text] [Related]
36. Influence of molar ratio on the combination effect of 5-fluorouracil with guanosine 5'-monophosphate on P388 and L1210 leukemias.
Iigo M; Hoshi A
Eur J Cancer Clin Oncol; 1984 Mar; 20(3):411-5. PubMed ID: 6323189
[TBL] [Abstract][Full Text] [Related]
37. In vivo generation of suppressor T cells by thymosin in congenitally athymic nude mice.
Marshall GD; Thurman GB; Rossio JL; Goldstein AL
J Immunol; 1981 Feb; 126(2):741-4. PubMed ID: 6161188
[TBL] [Abstract][Full Text] [Related]
38. Interaction of syngeneic, allogeneic and xenogeneic complement with murine leukaemia and carcinoma cells in vitro [proceedings].
Peeters P; Verloes R; Atassi G; Kanarek L
Arch Int Physiol Biochim; 1979 Oct; 87(4):836-8. PubMed ID: 93935
[No Abstract] [Full Text] [Related]
39. Synthesis and immunological effects of thymosin alpha 1 and its fragments on inhibitory factor in minimal change nephrotic syndrome.
Abiko T; Onodera I; Sekino H
Chem Pharm Bull (Tokyo); 1980 Dec; 28(12):3542-8. PubMed ID: 7226295
[No Abstract] [Full Text] [Related]
40. H2-antagonists and carmustine.
Dorr RT; Soble MJ
J Cancer Res Clin Oncol; 1989; 115(1):41-6. PubMed ID: 2564000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
